Cite

HARVARD Citation

    Zhu, M. et al. (2018). Blinatumomab Pharmacodynamics and Exposure–Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia. Journal of clinical pharmacology. pp. 168-179. [Online]. 
  
Back to record